Digital Breast Tomosynthesis Market
Report ID: SQMIG35A3838
Report ID: SQMIG35A3838
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3838 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
121
|Figures:
77
Global Digital Breast Tomosynthesis Market size was valued at USD 3.8 Billion in 2024 and is poised to grow from USD 4.26 Billion in 2025 to USD 10.54 Billion by 2033, growing at a CAGR of 12.0% during the forecast period (2026-2033).
The primary driver of the global digital breast tomosynthesis market is the clinical imperative for earlier and more accurate breast cancer detection, which has transformed screening practice globally. Digital breast tomosynthesis, a three-dimensional mammography technique, acquires slice images that improve lesion conspicuity and reduce overlapping tissue artifacts so radiologists can detect cancers that two-dimensional mammography often misses, especially in women with dense breasts. Since its clinical introduction and regulatory approvals in the 2000s and 2010s, adoption accelerated as hospitals and diagnostic centers replaced film systems with DBT-capable equipment from major vendors, generating measurable reductions in recall rates and unnecessary biopsies.Building on improved detection and lower recall rates, the most influential factor driving market expansion is technological innovation, AI-enabled image analysis and workflow integration, because they translate diagnostic gains into operational and economic value. When AI algorithms triage studies, prioritize suspicious findings and quantify lesion characteristics, radiologists spend less time per case, increasing screening throughput and making DBT financially viable for high-volume programs, which prompts payers to consider broader reimbursement. This cascade creates opportunities for vendors to offer modular upgrades, cloud-based analytics and retrofit kits, while public health initiatives can deploy mobile DBT in underserved regions to improve early detection.
How is AI improving diagnostic accuracy in the digital breast tomosynthesis market?
Automated Imaging Technology (AIT) has improved diagnostic accuracy in the digital breast tomosynthesis sector, by automating detection across volumetric image stacks and, through the use of algorithms, enabling the prioritization of suspicious exams for more focused review by radiologists. These algorithms provide a consistent second reading of examinations, help to reduce interpretive variability and enhance the visibility of lesions within dense breast tissue. Additionally, workflow tools that have been developed to facilitate the reconstruction of image slabs and to identify images with potential findings reduce the cognitive burden on radiologists and decrease the time it takes to interpret examinations while maintaining the integrity of the findings. As providers attempt to address an increased demand for imaging and the inadequate number of specialists available to provide imaging services, there is growing support in the marketplace for AIT. Both the recent publication of clinical data demonstrating a clearer localization of previously undetected cancers and improved consistency in the performance of readers when they utilize AI have contributed to this trend.
Lunit announced in April 2026 that it had received FDA approval for the latest enhancements and the installation of its AI powered mammography and breast tomosynthesis imaging capabilities into multiple sites across the United States. This will enhance market growth through improved confidence in detection, streamlined reporting, and the ability of sites to expand their capacity to perform breast imaging.
Market snapshot - (2026-2033)
Global Market Size
USD 3.8 Billion
Largest Segment
2D/3D Combination Systems
Fastest Growth
Upgradation Systems
Growth Rate
12.0% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global digital breast tomosynthesis market is segmented by product type, technology, application, end user and region. Based on product type, the market is segmented into DBT Equipment, 2D/3D Combination Systems, Standalone 3D Systems and Upgradation Systems. Based on technology, the market is segmented into Analog Tomosynthesis and Digital Tomosynthesis. Based on application, the market is segmented into Breast Cancer Screening, Diagnostic Imaging, Follow-up Imaging, Research Applications and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
DBT equipment segment dominates with digital breast tomosynthesis market share because established device manufacturers concentrate R&D, integrated imaging platforms and clinical validation around purpose-built tomosynthesis systems that address screening and diagnostic workflows. This comprehensive focus builds clinician confidence and drives procurement preferences, while integrated software and service offerings streamline image acquisition and interpretation, creating a reinforcing cycle of adoption that positions dedicated DBT systems as the primary clinical choice.
As per digital breast tomosynthesis market outlook, upgradation systems are emerging as the most rapidly expanding segment as providers seek cost effective ways to modernize existing mammography equipment. Regulatory encouragement and retrofit innovation accelerate demand, enabling facilities to add tomosynthesis capability quickly and generating new service and upgrade revenue streams that broaden market opportunity.
As per digital breast tomosynthesis market forecast, breast cancer screening segment dominates due to the global focus on detecting breast cancer early and through routine mammography screening programs. Digital breast tomosynthesis is widely used to screen because it allows for a better view of the lesions, has a higher rate of cancer detection, and has a lower rate of false-positive recalls when compared to traditional 2D mammography. Additionally, the breast cancer screening segment is supported by government-sponsored screening programs, an increasing number of women being made aware of preventive health measures, and a rise in the availability of advanced imaging systems in hospitals and diagnostic centers.
As per digital breast tomosynthesis market analysis, diagnostic imaging segment is expected to grow the quickest, as digital breast tomosynthesis is being increasingly used to evaluate suspicious breast abnormalities and dense breast tissue accurately. Digital breast tomosynthesis is gaining momentum in its use as a result of the increased demand by healthcare providers for advanced diagnostic methods, the increasing use of artificial intelligence in imaging, and the growing preference for accurate and minimally invasive means to diagnose.
To get detailed segments analysis, Request a Free Sample Report
North America leads the globe digital breast tomosynthesis market is driven by sophisticated clinical infrastructure, penetration of established providers and mature ecosystem for diagnostic innovation. Large hospital systems and specialized breast centers are allowing wide clinical use and integration into everyday workflow. Robust partnership with prominent research institutions and manufacturers fosters evidence generation and guideline influence. The well developed distribution, service and training networks ensure product uptime and clinician proficiency. A favorable reimbursement environment and continued investments in auxiliary technologies such as picture management and interpretation tools further support the depth of the industry. These systemic capabilities pave the stage for existing vendors and new entrants to scale solutions across varied care settings, continuing to lead the charge on technology acceptance and improvement of clinical practice.
As per globe digital breast tomosynthesis market regional outlook, United States is characterized by technology adoption across academic medical centers and integrated health systems, strong clinical research activity, and collaboration between vendors and clinical leaders. Established reimbursement pathways and specialized breast imaging networks enable broad deployment. Support infrastructure for training, service, and software integration improves clinical workflow. These elements create a sophisticated market environment that drives refinement of screening and diagnostic practices, improving care.
In Canada, the digital breast tomosynthesis market is marked by a coordinated uptake within provincial screening programs and hospital networks, supported by capital planning and clinical leadership. Manufacturers engage with healthcare providers for training, maintenance and workflow integration. Health policy promotes clinician acceptance by emphasizing quality and diagnostic accuracy. These dynamics have a role in the integration of tomosynthesis into normal breast imaging pathways.
Clinical guidelines are becoming standardized, screening programs are expanding and national health authorities are taking a proactive role in modernizing diagnostics all of which are driving significant growth in the Europe market. Variable uptake is possible, but information exchange is facilitated by a heterogeneous provider landscape including sophisticated academic centres, specialised breast clinics and national screening services. Robust local manufacturing capabilities and European regulatory alignment enable product availability and iterative innovation. Hospitals and imaging networks are investing because of a growing focus on diagnostic accuracy, patient experience and workflow efficiency. Cross-border clinical collaborations and multicenter research activities speed evidence production and guideline adoption, and targeted assistance for training and workforce development supports clinicians in integrating tomosynthesis into routine practice across different health systems.
As per globe digital breast tomosynthesis market regional forecast, Germany benefits from a strong domestic medtech industry, dense hospital network, and active clinical research community that shape procurement and clinical practice. Reimbursement mechanisms and regional screening initiatives support adoption across care settings. Close collaboration between manufacturers and academic sites fosters product refinement, training, and guideline influence. These elements position Germany as a leading market within Europe that adopts and influences innovation in breast imaging.
United Kingdom is marked by rising adoption driven by clinical leadership, evolving screening strategies, and emphasis on diagnostic quality. Investment in centralized imaging hubs and specialist breast centers supports wider uptake. Collaboration between health services and manufacturers enables pilots, training, and workflow optimization. Growing clinician familiarity and patient preference for enhanced imaging pathways sustain momentum. These factors accelerate integration of tomosynthesis into mainstream breast care.
As per globe digital breast tomosynthesis industry analysis, France is emerging as providers invest in diagnostic modernization and screening improvements. Adoption is concentrated in tertiary hospitals and regional breast centers that support evaluation and training. Collaborations between vendors and clinical networks drive pilots and service development. Policy focus on diagnostic quality and patient experience, combined with growing clinician interest, fosters integration of tomosynthesis into routine imaging pathways across public and private care settings.
Asia Pacific is strengthening its position in the Digital Breast Tomosynthesis market through strategic investments in clinical capacity, local manufacturing partnerships, and targeted adoption within advanced healthcare facilities. Countries in the region are prioritizing diagnostic modernization and technical training, enabling hospitals and specialty clinics to pilot and scale tomosynthesis solutions. Strong collaboration between domestic medical device companies and global vendors accelerates product localization and service support. Emphasis on integrating advanced imaging workflows, including software and interpretation tools, improves diagnostic throughput and clinician confidence. Regional knowledge exchange forums and collaborative research efforts further support technology diffusion, raising the region role as both an adopter and contributor to innovation in breast imaging.
Digital Breast Tomosynthesis Market in Japan features early adoption at academic centers and specialty hospitals, backed by a strong domestic device industry that works closely with clinicians. Focus on technological refinement, workflow integration, and diagnostic quality drives continuous improvement. Participation in collaborative research and targeted training programs strengthens clinician expertise. These attributes support Japan reputation for technological leadership and reinforce emphasis on precise imaging and service support in clinical settings.
Digital Breast Tomosynthesis Market in South Korea reflects adoption in advanced hospital systems, close collaboration with global and domestic vendors, and pronounced focus on imaging innovation. Emphasis on workflow efficiency and enhanced image interpretation supports uptake in centers and specialty clinics. Investment in training, service networks, and software integration strengthens clinician capability. These dynamics drive clinical integration and help establish South Korea as a regional hub for breast imaging innovation.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Clinical Screening Initiatives
Technological Advances In Tomosynthesis
High Equipment Acquisition Costs
Limited Reimbursement Coverage Variability
Request Free Customization of this report to help us to meet your business objectives.
Competitive landscape in the global digital breast tomosynthesis industry centers on AI-enabled differentiation, regulatory clearances, and distribution partnerships. Vendors pursue M&A, strategic alliances, and product innovation to secure clinical adoption; for example, an AI DBT clearance by a major developer and regional partner deals have accelerated deployments while startups target PACS integration and regional regulatory approvals to gain share.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global digital breast tomosynthesis market growth is propelled primarily by the clinical imperative for earlier and more accurate breast cancer detection, with AI and workflow integration serving as a strong secondary driver by improving throughput and diagnostic confidence. Adoption is led by North America where mature clinical infrastructure, reimbursement and research partnerships accelerate uptake, and the DBT equipment segment remains dominant as vendors focus R&D and integrated solutions on dedicated systems. Cost remains a significant restraint because high equipment acquisition expenditures and variable reimbursement slow purchases in budget constrained hospitals and smaller clinics, although retrofit upgradation options are expanding access. The global digital breast tomosynthesis market trend owing to the rising prevalence of breast cancer, increasing awareness regarding early cancer detection, and growing adoption of advanced 3D mammography technologies.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 3.8 Billion |
| Market size value in 2033 | USD 10.54 Billion |
| Growth Rate | 12.0% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Digital Breast Tomosynthesis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Digital Breast Tomosynthesis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Digital Breast Tomosynthesis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Digital Breast Tomosynthesis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Digital Breast Tomosynthesis Market size was valued at USD 3.8 Billion in 2024 and is poised to grow from USD 4.26 Billion in 2025 to USD 10.54 Billion by 2033, growing at a CAGR of 12.0% during the forecast period (2026-2033).
Competitive landscape in the global digital breast tomosynthesis market centers on AI-enabled differentiation, regulatory clearances, and distribution partnerships. Vendors pursue M&A, strategic alliances, and product innovation to secure clinical adoption; for example, an AI DBT clearance by a major developer and regional partner deals have accelerated deployments while startups target PACS integration and regional regulatory approvals to gain share. 'Hologic, Inc.', 'Siemens Healthineers AG', 'GE HealthCare Technologies Inc.', 'Fujifilm Holdings Corporation', 'Koninklijke Philips N.V.', 'Canon Inc.', 'Planmed Oy', 'Metaltronica S.p.A.', 'Konica Minolta, Inc.', 'Carestream Health, Inc.', 'Shimadzu Corporation', 'Analogic Corporation', 'Delphinus Medical Technologies, Inc.', 'Aurora Healthcare US Corp.', 'IMS Giotto S.p.A.', 'Internazionale Medico Scientifica S.r.l.', 'Hitachi, Ltd.', 'Samsung Electronics Co., Ltd.', 'Toshiba Corporation', 'Esaote SpA'
Expanding clinical screening initiatives and national awareness programs have strengthened demand for digital breast tomosynthesis by encouraging healthcare providers to upgrade diagnostic capabilities and incorporate advanced imaging into routine care pathways. As organized screening campaigns emphasize early detection and improved diagnostic accuracy, hospitals and clinics seek tomosynthesis systems that offer enhanced lesion visualization and workflow efficiency. This institutional prioritization of higher-quality imaging leads to increased procurement, training investments, and integration into clinical protocols, reinforcing market uptake across both public and private healthcare settings.
Ai-Enabled Diagnostic Precision: Advanced machine learning tools are increasingly integrated into tomosynthesis platforms to enhance lesion detection, prioritize studies, and support radiologist decision-making. These systems improve image interpretation consistency, assist in distinguishing benign from suspicious findings, and streamline reporting workflows. The qualitative improvements in diagnostic confidence and case triage foster greater clinical acceptance, support multidisciplinary care coordination, and encourage investment in upgraded systems that promise more reliable screening and diagnostic pathways across diverse patient populations, and reduce unnecessary recalls and downstream testing.
Why does North America Dominate the Global Digital Breast Tomosynthesis Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
